1Kunde D, Welch C. Ultracision in gynaecological laparoscopic surgery[J ]. J Obstet Gynaecol, 2003,23(4):347-352. 被引量：1
2Msezane LP, Katz MH. Gofrit ON, et al. Hemostatie agents and instruments in laparoscopic renal surgery [J].J Endourol,2008. 22(3):403-408. 被引量：1
3Lundblad RL, Bradshaw RA, Gabriel D, et al. A review of the therapeutic uses of thrombin [J]. Thromb Haemost, 2004,91(5): 851-860. 被引量：1
4Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant [J]. J Card Surg, 2003,18(6): 486-493. 被引量：1
5Mankad PS, Codispoti M.The role of fibrin sealants in hemostasis [ J ] .Am J Surg,2001.182(2):21-28. 被引量：1
6Wagner WR, Pachence JM, et al. Comparative in vitro analysis of topical hemostatic agents [ J ]. J Surg Res, 1996,66(2): 100-108. 被引量：1
7Gabay M. Absorbable hemostatic agents [J]. Am J Health Syst Pharm, 2006,63 ( 13): 1244-1253. 被引量：1
8Tomizawa Y. Clinical bencfils and risk analysis of topical hemostats: a review [ J ]. J Artif Organs, 2005,8(3): 137-142. 被引量：1
9Pusateri AE,Modrow HE,Harris RA,et al.Advaneed hemostatie dressing development program: animal model selection criteria and results of a study of nine hemostatie dressings in a model of severe large venous hemorrhage and hepatic injury in swine [J] .J Trauma,2003,55(3):518-526. 被引量：1
10Brodbelt AR, Miles JB, Foy PM, et al. Intraspinal oxidised cellulose (surgicel) causing delayed paraplegia after thoracotomy-a report of three cases [J]. Ann R Coil Surg Engl,2002,84 (2):97-99. 被引量：1
3Schreiber MA. Damage control surgery [ J ]. Crit Care Clin, 2004.20( 1 ) : 101 - 118. 被引量：1
4Rizoli SB, Nascimento B, Osman F, et al. Recombinant activated coagulation factor Ⅶ and bleeding trauma patients [ J]. J Trauma,2006,61 (6) : 1419 - 1425. 被引量：1
5Boffard KD, Riou B, Warren B, et al. Recombinant factor Ⅶa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebocontrolled, double-blind clinical trials [ J ]. J Trauma, 2005, 59(1) :8 -15. 被引量：1
6Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor Ⅶ a in liver transplantation due to chronic liver disease [ J ]. Liver Transpl, 2005,11 ( 8 ) : 895 - 900. 被引量：1
7Kenet G, Walden R, Eldad A, et al. Treatment of traumatic bleeding with recombinant factor Ⅶ a [ J ]. Lancet, 1999, 354 (9193) : 1879. 被引量：1
8Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor Ⅶ ( rF Ⅶ a) in uncontrolled bleeding: a report by the Israeli Muhidisciplinary rF Ⅶ a Task Force [ J ]. J Thromb Haemost, 2005,3 (4) : 640 - 648. 被引量：1
9Ranucci M, Isgro G, Soro G, et al. Efficacy and safety of recombinant activated factor Ⅶ in major surgical procedures: systematic review and meta-analysis of randomized clinical trials [ J ]. Arch Surg, 2008,143 ( 3 ) :296 - 304. 被引量：1
10Rossaint R, Cerny V, Coats TJ, et al. Key issues in advanced bleeding care in trauma. Shock ,2006,26:322-331. 被引量：1
